These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 189376

  • 21. Cell-mediated immune reactions to human tumors.
    Perlmann P, Troye M, Pape GR.
    Cancer; 1977 Jul; 40(1 Suppl):448-57. PubMed ID: 69485
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Leukocyte migration inhibition response to breast cancer antigens and to mouse mammary tumor virus in women with primary breast cancer.
    Fukuda M, Wanebo HJ, Tsuei L, Sarkar NH.
    Surg Forum; 1978 Jul; 29():167-9. PubMed ID: 233830
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Cellular immunity in mammary cancer patients as measured by the leukocyte migration test (LMT). A follow-up study.
    Rieche K, Arndt A, Pasternak G.
    Int J Cancer; 1976 Feb 15; 17(2):212-8. PubMed ID: 1248905
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Leukocyte migration inhibition and lymphocyte blastogenesis responses in breast carcinoma patients to mouse mammary tumor virus and to virion gp52 antigen and Rauscher murine leukemia virus-Kirsten sarcoma virus gp69/71 antigen.
    McCoy JL, Dean JH, Cannon GB, Jerome LJ, Alford TC, Parks WP, Gilden RV, Oroszlan ST, Herberman RB.
    J Natl Cancer Inst; 1978 Jun 15; 60(6):1259-67. PubMed ID: 206704
    [No Abstract] [Full Text] [Related]

  • 34. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
    Fritze D, Kaufmann M, Drings P, Fedra G.
    Oncology; 1978 Jun 15; 35(6):242-5. PubMed ID: 370704
    [Abstract] [Full Text] [Related]

  • 35. Role of H-2 histocompatibility on generation of cell-mediated cytotoxicity against virus-induced mammary tumors in C3H mice.
    Stutman O.
    Transplant Proc; 1977 Mar 15; 9(1):1153-5. PubMed ID: 194369
    [No Abstract] [Full Text] [Related]

  • 36. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
    Fukuda M, Wanebo HJ, Tsuei L, Ashikari R, Sarkar NH.
    J Natl Cancer Inst; 1980 Mar 15; 64(3):431-7. PubMed ID: 6243720
    [Abstract] [Full Text] [Related]

  • 37. Leukocyte migration inhibition responses to MCF-7, murine mammary tumor virus, and Thomsen-Friedenreich antigen in a series of cancer patients.
    Bernhard MI, Wanebo HJ, Helm J, Pace RC, Kaiser DL.
    Cancer Res; 1983 Apr 15; 43(4):1932-7. PubMed ID: 6299532
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.